# Glycemic Optimization Treatment Study

> **NCT00552370** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 5062 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Lantus®

## Key facts

- **NCT ID:** NCT00552370
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2005-03
- **Final completion:** 2005-03
- **Target enrollment:** 5062 (ACTUAL)
- **Last updated:** 2009-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00552370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00552370, "Glycemic Optimization Treatment Study". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00552370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*